OMNIAB, INC. Increase (Decrease) in Due to Related Parties, Current
OMNIAB, INC. (OABI) reported Increase (Decrease) in Due to Related Parties, Current of $41.75 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2022-05-20
- OMNIAB, INC. increase (decrease) in due to related parties, current for the quarter ending 2022-03-31 was $41.75K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 11 month |
|---|---|---|
| 2022-03-31 | $41.75K 10-Q · filed 2022-05-20 | |
| 2021-12-31 | $884.00 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |